Clinical Expert Consultant: Rheumatologist

Clinical Expert Consultant: RheumatologistEngagement Type: Short-term consulting (approx. 2–5 hours total)Location: RemoteCompensation: Competitive hourly consulting rateOverviewThe ACI Group is seeking a Rheumatologist with experience treating Psoriatic Arthritis (PsA) to serve as a Clinical Expert Consultant for a short-term engagement with CMS as part of the Medicare Drug Price Negotiation Program, created under the Inflation Reduction Act of 2022.CMS is conducting interviews with clinical experts to better understand the current treatment landscape and clinical considerations for specific conditions and associated therapies. The insights gathered will help inform CMS' evidence-based decision-making process related to high-cost drugs under the Medicare program.Role SummarySelected clinical expert will participate in a structured interview (typically 60 minutes) and may provide limited follow-up feedback (total estimated time commitment: 2–5 hours).Discussions will focus on clinical experience, treatment patterns, patient populations, and relevant medical evidence.Key ResponsibilitiesParticipate in a virtual interview with CMS representatives.Provide objective, evidence-based insights on current treatment options and clinical decision-making for Psoriatic Arthritis (PsA).Offer perspective on unmet needs, standard of care, and clinical factors influencing treatment outcomes.Review and provide limited feedback on interview materials if requested.Maintain confidentiality and comply with all CMS participation requirements.QualificationsBoard certified Rheumatologist.Active clinical practice or recent experience treating patients with Psoriatic Arthritis (PsA).Knowledge of current clinical guidelines and therapeutic options within the specialty area.Experience contributing to clinical guideline development (preferred).Active involvement in research (preferred).Strong communication skills and ability to clearly articulate clinical reasoning.Time CommitmentApprox. 2–5 hours total (includes interview, preparation, and any follow-up correspondence).Flexible scheduling; interviews conducted remotely via videoconference.Opportunity for continued participation in future project phases.About the CMS Drug Price Negotiation ProgramThrough the Inflation Reduction Act of 2022, CMS now directly negotiates prices for select high-cost drugs. As part of this effort, CMS engages independent clinical experts to gather perspectives on the clinical use, effectiveness, and value of these therapies. Clinicians provide insight into real-world treatment considerations but are not involved in any price-setting discussions or negotiations.